Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Orion Biotech Opportunities Corp. quarterly Debt-to-equity history and growth rate from Q1 2022 to Q4 2022.
Orion Biotech Opportunities Corp. Debt-to-equity for the quarter ending December 31, 2022 was -110 %.
Debt-to-equity, Quarterly (%)
Period
Value
YoY Chg
Change %
Date
Q4 2022
-110
Dec 31, 2022
Q3 2022
-111
Sep 30, 2022
Q2 2022
-112
Jun 30, 2022
Q1 2022
-112
Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.